Masimo Ebit vs Research Development Analysis

MASI Stock

USD 168.12 4.47 2.73%

Masimo financial indicator trend analysis is infinitely more than just investigating Masimo recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Masimo is a good investment. Please check the relationship between Masimo Ebit and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.

Ebit vs Research Development

Ebit vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Masimo Ebit account and Research Development. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Masimo's Ebit and Research Development is -0.3. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Research Development in the same time period over historical financial statements of Masimo, assuming nothing else is changed. The correlation between historical values of Masimo's Ebit and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Masimo are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Ebit i.e., Masimo's Ebit and Research Development go up and down completely randomly.

Correlation Coefficient

-0.3

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ebit

Research Development

Most indicators from Masimo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Masimo current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.As of now, Masimo's Selling General Administrative is increasing as compared to previous years. The Masimo's current Sales General And Administrative To Revenue is estimated to increase to 0.59, while Tax Provision is forecasted to increase to (380 K).

	2022	2023	2024	2025 (projected)
Total Operating Expenses	848.8M	867.0M	1.3B	1.3B
Cost Of Revenue	977M	1.0B	1.1B	1.1B

Total Operating Expenses Cost Of Revenue

Masimo fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Other Assets	Other Liab	Current Deferred Revenue
Common Stock Shares Outstanding		-0.31	-0.5	-0.37	-0.44	0.08	-0.38	-0.53	-0.24	-0.41	0.29	-0.39	-0.43	0.29	-0.38	-0.48	-0.38	-0.29	0.64	-0.47	-0.41	-0.16	-0.2	0.45	-0.46	-0.1
Total Assets	-0.31		0.87	0.95	0.95	0.76	0.98	0.58	0.95	0.94	0.24	0.97	0.7	0.23	0.96	0.89	0.97	0.92	-0.9	0.92	0.95	0.94	0.74	-0.45	0.93	0.78
Short Long Term Debt Total	-0.5	0.87		0.87	0.95	0.38	0.84	0.9	0.7	0.98	-0.25	0.96	0.72	-0.25	0.93	1.0	0.95	0.92	-0.94	0.99	0.91	0.67	0.76	-0.78	0.95	0.55
Other Current Liab	-0.37	0.95	0.87		0.97	0.63	0.93	0.61	0.89	0.94	0.18	0.92	0.85	0.17	0.98	0.87	0.94	0.92	-0.88	0.91	0.9	0.9	0.56	-0.46	0.95	0.73
Total Current Liabilities	-0.44	0.95	0.95	0.97		0.56	0.93	0.75	0.85	0.99	0.01	0.97	0.81	0.0	0.99	0.95	0.98	0.95	-0.94	0.98	0.94	0.84	0.68	-0.61	0.99	0.7
Total Stockholder Equity	0.08	0.76	0.38	0.63	0.56		0.77	-0.03	0.89	0.51	0.73	0.62	0.29	0.72	0.59	0.41	0.61	0.54	-0.5	0.46	0.65	0.88	0.52	0.13	0.49	0.78
Property Plant And Equipment Net	-0.38	0.98	0.84	0.93	0.93	0.77		0.54	0.96	0.9	0.28	0.94	0.69	0.28	0.93	0.85	0.95	0.88	-0.9	0.88	0.96	0.94	0.69	-0.39	0.9	0.72
Net Debt	-0.53	0.58	0.9	0.61	0.75	-0.03	0.54		0.33	0.81	-0.64	0.75	0.57	-0.64	0.72	0.89	0.75	0.75	-0.77	0.85	0.68	0.3	0.65	-0.92	0.78	0.26
Retained Earnings	-0.24	0.95	0.7	0.89	0.85	0.89	0.96	0.33		0.8	0.5	0.86	0.63	0.49	0.87	0.72	0.87	0.79	-0.8	0.77	0.89	0.99	0.61	-0.21	0.81	0.79
Accounts Payable	-0.41	0.94	0.98	0.94	0.99	0.51	0.9	0.81	0.8		-0.08	0.98	0.78	-0.09	0.98	0.98	0.98	0.96	-0.93	0.99	0.94	0.79	0.73	-0.71	0.99	0.64
Cash	0.29	0.24	-0.25	0.18	0.01	0.73	0.28	-0.64	0.5	-0.08		0.01	0.03	0.99	0.06	-0.22	0.02	-0.04	0.06	-0.15	0.09	0.54	-0.12	0.68	-0.05	0.4
Non Current Assets Total	-0.39	0.97	0.96	0.92	0.97	0.62	0.94	0.75	0.86	0.98	0.01		0.68	0.0	0.97	0.97	0.99	0.95	-0.95	0.98	0.96	0.83	0.82	-0.62	0.95	0.73
Non Currrent Assets Other	-0.43	0.7	0.72	0.85	0.81	0.29	0.69	0.57	0.63	0.78	0.03	0.68		0.02	0.82	0.7	0.74	0.75	-0.71	0.74	0.7	0.67	0.16	-0.52	0.85	0.37
Cash And Short Term Investments	0.29	0.23	-0.25	0.17	0.0	0.72	0.28	-0.64	0.49	-0.09	0.99	0.0	0.02		0.05	-0.23	0.01	-0.05	0.08	-0.15	0.08	0.53	-0.13	0.65	-0.06	0.36
Net Receivables	-0.38	0.96	0.93	0.98	0.99	0.59	0.93	0.72	0.87	0.98	0.06	0.97	0.82	0.05		0.94	0.98	0.95	-0.92	0.97	0.93	0.87	0.67	-0.59	0.98	0.71
Non Current Liabilities Total	-0.48	0.89	1.0	0.87	0.95	0.41	0.85	0.89	0.72	0.98	-0.22	0.97	0.7	-0.23	0.94		0.96	0.93	-0.94	0.99	0.9	0.69	0.79	-0.77	0.95	0.6
Inventory	-0.38	0.97	0.95	0.94	0.98	0.61	0.95	0.75	0.87	0.98	0.02	0.99	0.74	0.01	0.98	0.96		0.97	-0.93	0.97	0.97	0.85	0.75	-0.62	0.98	0.67
Other Current Assets	-0.29	0.92	0.92	0.92	0.95	0.54	0.88	0.75	0.79	0.96	-0.04	0.95	0.75	-0.05	0.95	0.93	0.97		-0.84	0.94	0.91	0.8	0.69	-0.63	0.95	0.62
Other Stockholder Equity	0.64	-0.9	-0.94	-0.88	-0.94	-0.5	-0.9	-0.77	-0.8	-0.93	0.06	-0.95	-0.71	0.08	-0.92	-0.94	-0.93	-0.84		-0.95	-0.92	-0.75	-0.73	0.63	-0.94	-0.65
Total Liab	-0.47	0.92	0.99	0.91	0.98	0.46	0.88	0.85	0.77	0.99	-0.15	0.98	0.74	-0.15	0.97	0.99	0.97	0.94	-0.95		0.92	0.75	0.76	-0.73	0.97	0.64
Property Plant And Equipment Gross	-0.41	0.95	0.91	0.9	0.94	0.65	0.96	0.68	0.89	0.94	0.09	0.96	0.7	0.08	0.93	0.9	0.97	0.91	-0.92	0.92		0.85	0.72	-0.54	0.93	0.6
Total Current Assets	-0.16	0.94	0.67	0.9	0.84	0.88	0.94	0.3	0.99	0.79	0.54	0.83	0.67	0.53	0.87	0.69	0.85	0.8	-0.75	0.75	0.85		0.55	-0.18	0.8	0.78
Intangible Assets	-0.2	0.74	0.76	0.56	0.68	0.52	0.69	0.65	0.61	0.73	-0.12	0.82	0.16	-0.13	0.67	0.79	0.75	0.69	-0.73	0.76	0.72	0.55		-0.53	0.64	0.66
Other Assets	0.45	-0.45	-0.78	-0.46	-0.61	0.13	-0.39	-0.92	-0.21	-0.71	0.68	-0.62	-0.52	0.65	-0.59	-0.77	-0.62	-0.63	0.63	-0.73	-0.54	-0.18	-0.53		-0.68	-0.08
Other Liab	-0.46	0.93	0.95	0.95	0.99	0.49	0.9	0.78	0.81	0.99	-0.05	0.95	0.85	-0.06	0.98	0.95	0.98	0.95	-0.94	0.97	0.93	0.8	0.64	-0.68		0.61
Current Deferred Revenue	-0.1	0.78	0.55	0.73	0.7	0.78	0.72	0.26	0.79	0.64	0.4	0.73	0.37	0.36	0.71	0.6	0.67	0.62	-0.65	0.64	0.6	0.78	0.66	-0.08	0.61

Click cells to compare fundamentals

Masimo Account Relationship Matchups

Masimo fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	58.0M	57.7M	55.2M	54.1M	53.3M	52.8M
Total Assets	1.7B	1.9B	3.2B	3.0B	2.6B	2.8B
Short Long Term Debt Total	34.3M	32.7M	975.4M	970M	846.1M	888.4M
Other Current Liab	141.8M	155.4M	247M	188.1M	262.6M	275.7M
Total Current Liabilities	233.8M	267.7M	630M	563.8M	617.7M	648.6M
Total Stockholder Equity	1.4B	1.6B	1.3B	1.4B	1.1B	560.8M
Property Plant And Equipment Net	272.5M	272.8M	402.5M	483.5M	381.6M	400.7M
Net Debt	(607.1M)	(712.6M)	772.5M	807M	668.5M	701.9M
Retained Earnings	1.3B	1.6B	1.7B	1.8B	1.5B	1.6B
Accounts Payable	64.1M	75.6M	276.8M	251.5M	252.8M	265.4M
Cash	641.4M	745.3M	202.9M	163M	177.6M	220.6M
Non Current Assets Total	611.4M	648.6M	1.9B	1.8B	1.4B	1.5B
Non Currrent Assets Other	114.4M	136.5M	215.2M	149M	679M	713.0M
Cash And Short Term Investments	641.4M	745.3M	202.9M	163M	177.6M	228.7M
Net Receivables	181.4M	244.7M	505.1M	421M	489.3M	513.8M
Liabilities And Stockholders Equity	1.7B	1.9B	3.2B	3.0B	2.6B	2.8B
Non Current Liabilities Total	71.1M	69.0M	1.2B	1.1B	956.1M	1.0B
Inventory	216.0M	201.4M	501M	545M	459.2M	482.2M
Other Current Assets	62.4M	37.1M	99.6M	102.9M	99.7M	104.7M
Other Stockholder Equity	65.0M	(15.2M)	(387M)	(385.8M)	(330.9M)	(314.4M)
Total Liab	304.9M	336.8M	1.9B	1.7B	1.6B	1.7B
Property Plant And Equipment Gross	304.8M	463.4M	673.6M	1.1B	752.2M	789.8M
Total Current Assets	1.1B	1.2B	1.3B	1.2B	1.2B	1.3B
Accumulated Other Comprehensive Income	1.4M	(5.5M)	11.5M	(45.3M)	(108.2M)	(102.8M)
Intangible Assets	73.9M	72.5M	722.6M	652.3M	90.4M	94.5M
Other Assets	105.3M	161.7M	203.0M	300K	345K	327.8K
Other Liab	40.2M	71.1M	69.0M	246.7M	283.7M	297.9M
Current Deferred Revenue	44.9M	50.9M	80.6M	37.4M	46.8M	31.8M
Good Will	103.2M	100.3M	445.4M	407.7M	96.7M	73.1M
Short Term Debt	6.0M	6.4M	33.8M	70.7M	81.3M	85.4M
Common Stock	53K	54K	55K	100K	115K	63.2K
Property Plant Equipment	219.6M	272.5M	272.8M	402.5M	462.9M	486.0M
Treasury Stock	(526.6M)	(638.7M)	(767.7M)	(1.2B)	(1.1B)	(999.7M)
Net Tangible Assets	1.1B	1.2B	1.4B	631.5M	726.2M	670.8M
Retained Earnings Total Equity	1.1B	1.3B	1.6B	1.7B	2.0B	2.1B

Currently Active Assets on Macroaxis

AMT	American Tower Corp
HLTOY	Hellenic Telecommunications Org
NFLX	Netflix
EPGFX	Europac Gold Fund
FTGFF	Firan Technology Group

When determining whether Masimo offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Masimo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Masimo Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Masimo Stock:

How To Invest In Masimo

Details

Is Masimo Stock a good investment?

Details

What is Masimo's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Masimo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in Masimo Stock please use our How to Invest in Masimo guide.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Masimo. If investors know Masimo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Masimo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.10)

Earnings Share

(5.73)

Revenue Per Share

39.295

Quarterly Revenue Growth

0.094

Return On Assets

0.0061

The market value of Masimo is measured differently than its book value, which is the value of Masimo that is recorded on the company's balance sheet. Investors also form their own opinion of Masimo's value that differs from its market value or its book value, called intrinsic value, which is Masimo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Masimo's market value can be influenced by many factors that don't directly affect Masimo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Masimo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Masimo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Masimo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Masimo Ebit vs Research Development Analysis

Ebit vs Research Development

Ebit vs Research Development Correlation Analysis

Correlation Coefficient

Ebit

Research Development

Masimo fundamental ratios Correlations

Masimo Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Masimo fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Accounts Payable	+ 0.99	Total Current Liabilities
Net Receivables	+ 0.99	Total Current Liabilities
Other Liab	+ 0.99	Total Current Liabilities
Total Current Assets	+ 0.99	Retained Earnings

Total Liab	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Non Current Assets Total
Other Liab	- 0.94	Other Stockholder Equity
Other Stockholder Equity	- 0.94	Non Current Liabilities Total
Other Stockholder Equity	- 0.94	Total Current Liabilities
Other Stockholder Equity	- 0.94	Short Long Term Debt Total